Pfanstiehl, Inc.
Hetal Bhatt is an experienced scientist currently serving as a Method Development and Validation Senior Scientist at Pfanstiehl, Inc. since November 2019. Previously, Hetal worked at Pfizer in Bioanalytical R&D from 2014 to November 2019, leading force degradation studies and developing HPLC methods for large molecules. Hetal's earlier experience includes roles as a Senior Lab Analyst at AbbVie and as a Senior Lab Analyst at Abbott Laboratories, where support was provided in various testing laboratories for API and finished products. Hetal began a professional career at Abbott as a Quality Control Laboratory Technician, assisting in fermentation and chemical manufacturing processes. Hetal holds a Bachelor of Science degree in Chemistry from the University of Mumbai and has pursued further education at the University of Parkside.
This person is not in any teams
Pfanstiehl, Inc.
1 followers
Founded in 1919 by Carl A. Pfanstiehl, our company specializes in isolation, purification, custom synthesis and scale-up development of cGMP, high purity and low endotoxin (HPLE) Injectable Formulation Components, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API’s), in gram to multi-ton commercial quantities. Tried and true parenteral excipients include trehalose, sucrose, mannitol, maltose, sorbitol, and hydroxypropyl betacyclodextrin. Upstream, high purity media components include animal component free galactose, mannose, and L-arginine. At Pfanstiehl we pride ourselves on being customer focused and are amenable to producing cGMP components on a custom basis to solve formulation challenges for our clients.